{
  "report_rows": [
    {
      "kpi": "Q2 2026 net sales",
      "prediction": "BEAT",
      "answer": "pred ~$6.70B vs. cons $6.59B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 operating EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.27 vs. cons $2.23",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 operating EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$2.21B vs. cons $2.18B",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Operating EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$3.80 midpoint vs. cons $3.75 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating EBITDA guidance",
      "prediction": "BETTER",
      "answer": "guide ~$4.25B midpoint vs. cons $4.20B (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.6,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.4,
  "day5_path": "FADE",
  "day5_rationale": "The projected FY2026 EPS guide of ~$3.80 versus consensus $3.75 largely incorporates the Q2 beat: predicted first-half EPS is ~$3.77 versus consensus ~$3.73, leaving implied second-half EPS of only ~$0.03 versus consensus ~$0.02. With little out-period estimate upside and elevated expectations, the initial positive residual should fade.",
  "day5_confidence": "MEDIUM"
}